Biologics Reduce Symptoms of Alcohol Intolerance Better than Aspirin Desensitization in Patients with N-ERD and Nasal Polyps.
Ulrike Foerster-RuhrmannMiroslav JurkovAgnieszka J SzczepekKarl-Christian BergmannJoachim Wilhelm FluhrHeidi OlzePublished in: Biomedicines (2024)
This real-world study shows that alcohol-related respiratory symptoms are a relevant parameter in CRSwNP/N-ERD patients. Patients benefit more from biologic therapy than from ATAD in terms of their alcohol-related symptoms and other CRS symptoms. Future studies should include placebo-controlled oral alcohol challenge.
Keyphrases
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- low dose
- peritoneal dialysis
- prognostic factors
- squamous cell carcinoma
- alcohol consumption
- type diabetes
- randomized controlled trial
- depressive symptoms
- cardiovascular disease
- patient reported outcomes
- radiation therapy
- placebo controlled
- percutaneous coronary intervention
- acute coronary syndrome
- atrial fibrillation
- antiplatelet therapy
- phase iii